Literature DB >> 31165487

Surgical treatment of Milroy disease.

A Bolletta1,2, G Di Taranto1,3, S H Chen4, R Elia1,5, V Amorosi1,6, J Cy Chan1, H C Chen1.   

Abstract

BACKGROUND AND OBJECTIVES: Milroy disease is a form of congenital primary lymphedema affecting the lower limbs. When conservative management is ineffective, surgical treatment becomes necessary. The purpose of this study was to investigate the efficacy of vascularized lymph node transfer (VLNT) associated with extensive therapeutic lipectomy in the treatment of these patients.
METHODS: In China Medical University Hospital, four patients have been diagnosed with Milroy disease and treated over an 8 year-period time. All patients presented with hereditary bilateral legs swelling since birth. All patients were treated with VLNT from the gastroepiploic region bilaterally associated with extensive therapeutic lipectomy.
RESULTS: All procedures have been executed bilaterally and have been successful, without complications. The average follow-up of the patients was 20.2 ± 2.8 months. The limbs treated presented an average circumference reduction of a 4.0 ± 2.1 cm and patients did not experience cellulitis during follow-up. Patients expressed satisfaction with the procedure.
CONCLUSIONS: VLNT together with therapeutic lipectomy proved to be a reliable technique in moderate cases of Milroy disease, providing an alternative path for lymph drainage, and reducing the lymph load and the excess of subcutaneous adipose tissues, thus improving patients' quality of life.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Milroy disease; congenital lymphedema; extensive therapeutic lipectomy; lymph node transfer; lymphedema surgery

Mesh:

Year:  2019        PMID: 31165487     DOI: 10.1002/jso.25583

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  Surgical management of lymphedema: a review of current literature.

Authors:  Kitae E Park; Omar Allam; Ludmila Chandler; Mohammad Ali Mozzafari; Catherine Ly; Xiaona Lu; John A Persing
Journal:  Gland Surg       Date:  2020-04

2.  Treatment of Early-Stage Gynecological Cancer-Related Lower Limb Lymphedema by Lymphaticovenular Anastomosis-The Triple Incision Approach.

Authors:  Anna Amelia Caretto; Gianluigi Stefanizzi; Giorgia Garganese; Simona Maria Fragomeni; Alex Federico; Luca Tagliaferri; Bruno Fionda; Alessandro Cina; Giovanni Scambia; Stefano Gentileschi
Journal:  Medicina (Kaunas)       Date:  2022-05-01       Impact factor: 2.948

3.  The Combination of Lymph Node Transfer and Excisional Procedures in Bilateral Lower Extremity Lymphedema: Clinical Outcomes and Quality of Life Assessment with Long-Term Follow-Up.

Authors:  Luigi Losco; Alberto Bolletta; Alessandro de Sire; Shih-Heng Chen; Gokhan Sert; Dicle Aksoyler; Jonathan Velazquez-Mujica; Marco Invernizzi; Emanuele Cigna; Hung-Chi Chen
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

Review 4.  Animal models in lymph node transfer surgery: A systematic review.

Authors:  Abdullah S Eldaly; Francisco R Avila; Ricardo A Torres-Guzman; Karla C Maita; John P Garcia; Luiza P Serrano; Humza Y Saleem; Antonio J Forte
Journal:  J Clin Transl Res       Date:  2022-05-25

Review 5.  Surgical Treatment and Rehabilitation Strategies for Upper and Lower Extremity Lymphedema: A Comprehensive Review.

Authors:  Alessandro de Sire; Luigi Losco; Lorenzo Lippi; Davide Spadoni; Juste Kaciulyte; Gokhan Sert; Paola Ciamarra; Marco Marcasciano; Roberto Cuomo; Alberto Bolletta; Marco Invernizzi; Emanuele Cigna
Journal:  Medicina (Kaunas)       Date:  2022-07-19       Impact factor: 2.948

6.  Prevention of Secondary Lymphedema after Complete Lymph Node Dissection in Melanoma Patients: The Role of Preventive Multiple Lymphatic-Venous Anastomosis in Observational Era.

Authors:  Eleonora Nacchiero; Michele Maruccia; Fabio Robusto; Rossella Elia; Alessio Di Cosmo; Giuseppe Giudice
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.